Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Single Center Experience of " Mobilize，Collect and Transplant, No Cryopreservation" Integrated Autologous Hematopoietic Stem Cells Transplantation Strategy for Newly Diagnosed Multiple Myeloma

Xi Yang, Chenglong Li, Feifei Che, Hong Zheng, Jiao Chen, Xiaobing Huang

Blood (2022) 140 (Supplement 1): 12930.

https://doi.org/10.1182/blood-2022-168915

Published: 2022

Journal Articles

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Cheng Chen, Lin He, Xi Wang, Zichen Ye, Rong Xiao, Hong Zheng, Shu Chen, Hui Li, Xi Yang, Xuemei Wang, Yu Wang, Xuemei Ye, Xiaobing Huang, Jingying Dai

Blood (2022) 140 (Supplement 1): 12439.

https://doi.org/10.1182/blood-2022-157665

Published: 2022

Journal Articles

Data of Daratumumab from a Real-World Single-Center Study

Jun Wang, Jiafei Wu, Xi Yang, Hong Zheng, Yijing Wang, Boyue Zheng, Feiyang Li, Hui Li

Blood (2022) 140 (Supplement 1): 12650.

https://doi.org/10.1182/blood-2022-170588

Published: 2022

Journal Articles

Prevalence and Risk Factor for Hepatocellular Carcinoma in Individuals with Hemophilia in the Era of Direct-Acting Antiviral Agents: A National Inpatient Sample Study

XI Yang, Kwonho Jeong, Jonathan G. Yabes, Margaret V. Ragni

Blood (2021) 138 (Supplement 1): 593.

https://doi.org/10.1182/blood-2021-151713

Published: 2021

Journal Articles

High-Dose Intravenous Acyclovir Is Safe and Effective in the Treatment of EBV Reactivation Post Allogeneic Hematopoietic Stem Cell Transplantation

Yu Wang, Xuemei Ye, Hong Zheng, Yan Mao, Xuemei Wang, Feifei Che, Chunsen Wang, Xi Yang, Xiaobing Huang

Blood (2021) 138 (Supplement 1): 4863.

https://doi.org/10.1182/blood-2021-149569

Published: 2021

Journal Articles

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Wangjun Cao, Lin He, Hong Zheng, MDPhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD, Jingying Dai, PhD

Blood (2020) 136 (Supplement 1): 53–54.

https://doi.org/10.1182/blood-2020-138462

Published: 2020

Journal Articles

This Is a Title: Single-Center Data Report of Clhag Regimen for R/R-AML Patients

Chuanyan Jiang, Yu Wang, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Xi Yang, Hui LI, MD

Blood (2020) 136 (Supplement 1): 3.

https://doi.org/10.1182/blood-2020-139708

Published: 2020

Journal Articles

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Yu Wang, Chuanyan Jiang, Xi Yang, Jingying Dai, PhD, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Hui LI, MD

Blood (2020) 136 (Supplement 1): 26.

https://doi.org/10.1182/blood-2020-139729

Published: 2020

Journal Articles

Assay Specificity and Sensitivity Evaluation of Cepheid GeneXpert ® NPM1 Prototype for Mutation Detection in Acute Myeloid Leukemia

Xi Yang, PhD, Krupa Shridhar, Jayashree Sanjeeviraman, Gwo-Jen Day, PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-140809

Published: 2020

Journal Articles

Efficacy and Safety Evaluation of Elderly Patients with AML Based on Clinical Common Chemotherapy Regimens Under Real-World Events

Yu Wang, Mengying Zou, Xi Yang, Li Hui, Hong Zheng, MD PhD

Blood (2019) 134 (Supplement_1): 5109.

https://doi.org/10.1182/blood-2019-128608

Published: 2019

Journal Articles

The Increase on Th1 and CD8+T Levels While a Decrease on Treg Level after Dasatinib Treatment Indicate a Better Therapeutic Response to Dasatinib and Deeper Clinical Remission in Chronic Myelogenous Leukemia Patients

Jingying Dai, PhD, Hong Zheng, MD PhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD

Blood (2019) 134 (Supplement_1): 5376.

https://doi.org/10.1182/blood-2019-128413

Published: 2019

Journal Articles

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Xi Yang, Chenglong Li, MDand PhD, Rong Zhang, MDand PhD, Hong Zheng, MD PhD, Qing Wei, MD PhD, Chunsen Wang, MD, Jingying Dai, PhD, Xiaobing Huang, Ningning Tang

Blood (2019) 134 (Supplement_1): 2034.

https://doi.org/10.1182/blood-2019-124419

Published: 2019

Journal Articles

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Chenglong Li, MDand PhD, Xi Yang, Jingying Dai, PhD, Ningning Tang, Hong Zheng, MD PhD, Chunsen Wang, MD, Xiaobing Huang

Blood (2019) 134 (Supplement_1): 1966.

https://doi.org/10.1182/blood-2019-126632

Published: 2019

Journal Articles

Dasatinib Significantly Enhances the Level of Th1 Cells While Decreases the Level of Treg Cells in Chronic Myeloid Leukemia Patients, and Th1 Can be a Potential Marker for Evaluating the Therapeutic Efficacy and Prognosis

Jingying Dai, PhD, Xi Yang, Xiaobing Huang, Hong Zheng, MD PhD, Xiaodong Wang, MD

Blood (2018) 132 (Supplement 1): 4272.

https://doi.org/10.1182/blood-2018-99-113032

Published: 2018

Journal Articles

Identification and Characterization of EBV Genome in NKT Cell Lymphoma

Yi Su, MD, Xi Yang, Hai Yi, MD, Fangyi Fan, Haoping Sun, Sihan Lai, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 5304.

https://doi.org/10.1182/blood-2018-99-118710

Published: 2018

Journal Articles

Epigenetic Therapy Targets Th1/Th17 Polarization to Reversing Immune Evasion and Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation in Non-APL AML Patients

Xi Yang, Hong Zheng, MD PhD, Jingying Dai, PhD, Chenglong Li, MDand PhD, Rong Zhang, MD PhD, Xiaodong WANG, MD, Chunsen Wang, MD, Xiaobing Huang

Blood (2018) 132 (Supplement 1): 3424.

https://doi.org/10.1182/blood-2018-99-111671

Published: 2018

Journal Articles

This Is a Title in Chidamide, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO

Xi Yang, Xiaobing Huang, MDand PhD, Hong Zheng, MDPhD, Chenglong Li, MDand PhD, Jingying Dai, PhD, Rong Zhang, MDand PhD, Xiaodong Wang, PhD, Chunsen Wang, MD

Blood (2017) 130 (Supplement 1): 3278.

https://doi.org/10.1182/blood.V130.Suppl_1.3278.3278

Published: 2017

Journal Articles

The High Expression of CFTR in Ph+ Acute Leukemia Regulates the BCR-ABL and Wnt/ -Catenin Signaling Pathway Via Interaction with PP2A Protein

Xi Yang, Yuping Gong, MDPhD

Blood (2015) 126 (23): 1252.

https://doi.org/10.1182/blood.V126.23.1252.1252

Published: 2015

Journal Articles

Rapamycin Can Reduce Apoptosis of CD4+CD25+ Regulatory T Cells from Mouse Model of Severe Aplastic Anemia

Zenghua Lin, MD, Hong Liu, MD PhD, Li Zhu, Xuli Wang, Yu Qian, Xi Yang, Xin Cao, Yifeng Cai, MD PhD, Yaping Zhang, Guoqi Song, MD, Juan Qian

Blood (2014) 124 (21): 2946.

https://doi.org/10.1182/blood.V124.21.2946.2946

Published: 2014

Journal Articles

Anti-Leukemia Effect of Rapamycin Alone or Plus Daunorubicin on Acute Lymphoblastic Leukemia Cell Lines

Xi Yang, Yuping Gong, Ting Niu, MD, PhD

Blood (2010) 116 (21): 3256.

https://doi.org/10.1182/blood.V116.21.3256.3256

Published: 2010

NARROW

Single Center Experience of " Mobilize，Collect and Transplant, No Cryopreservation" Integrated Autologous Hematopoietic Stem Cells Transplantation Strategy for Newly Diagnosed Multiple Myeloma

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Data of Daratumumab from a Real-World Single-Center Study

Prevalence and Risk Factor for Hepatocellular Carcinoma in Individuals with Hemophilia in the Era of Direct-Acting Antiviral Agents: A National Inpatient Sample Study

High-Dose Intravenous Acyclovir Is Safe and Effective in the Treatment of EBV Reactivation Post Allogeneic Hematopoietic Stem Cell Transplantation

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

This Is a Title: Single-Center Data Report of Clhag Regimen for R/R-AML Patients

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Assay Specificity and Sensitivity Evaluation of Cepheid GeneXpert ® NPM1 Prototype for Mutation Detection in Acute Myeloid Leukemia

Efficacy and Safety Evaluation of Elderly Patients with AML Based on Clinical Common Chemotherapy Regimens Under Real-World Events

The Increase on Th1 and CD8+T Levels While a Decrease on Treg Level after Dasatinib Treatment Indicate a Better Therapeutic Response to Dasatinib and Deeper Clinical Remission in Chronic Myelogenous Leukemia Patients

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Dasatinib Significantly Enhances the Level of Th1 Cells While Decreases the Level of Treg Cells in Chronic Myeloid Leukemia Patients, and Th1 Can be a Potential Marker for Evaluating the Therapeutic Efficacy and Prognosis

Identification and Characterization of EBV Genome in NKT Cell Lymphoma

Epigenetic Therapy Targets Th1/Th17 Polarization to Reversing Immune Evasion and Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation in Non-APL AML Patients

This Is a Title in Chidamide, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO

The High Expression of CFTR in Ph+ Acute Leukemia Regulates the BCR-ABL and Wnt/ -Catenin Signaling Pathway Via Interaction with PP2A Protein

Rapamycin Can Reduce Apoptosis of CD4+CD25+ Regulatory T Cells from Mouse Model of Severe Aplastic Anemia

Anti-Leukemia Effect of Rapamycin Alone or Plus Daunorubicin on Acute Lymphoblastic Leukemia Cell Lines

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only